Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

539

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

October 31, 2008

Conditions
Low Back Pain
Interventions
DRUG

Buprenorphine transdermal system

Buprenorphine transdermal system 10 or 20 mcg/h worn for 7 days

DRUG

Placebo

transdermal system (placebo) worn for 7 days

Trial Locations (86)

10004

Research Facility, New York

10022

Research Facility, New York

16025

Research Facility, Chicora

16602

Research Facility, Altoona

16635

Research Facility, Duncansville

17055

Research Facility, Mechanicsburg

19611

Research Facility, West Reading

24018

Research Facility, Roanoke

27401

Research Facility, Greensboro

28209

Research Facility, Charlotte

28655

Research Facility, Morgantown

29621

Anderson Family Care, PA, Anderson

30033

Druid Oaks Health Center, Decatur

30060

Research Facility, Marietta

30066

Research Facility, Marietta

30327

Independent Neurodiagnostic Clinic, Atlanta

30534

Research Facility, Dawsonville

32127

Research Facility, Port Orange

32720

University Clinical Research, DeLand

32806

Research Facility, Orlando

32953

Research Facility, Merritt Island

33126

Pharmax Research Clinic, Miami

33324

Research Facility, Plantation

33409

Research Facility, West Palm Beach

33484

Arthritis Associates of S. FL, Delray Beach

33603

Clinical Research of West Flor, Tampa

33613

Research Facility, Tampa

33765

Clinical Research of West Florida, Clearwater

Research Facility, Clearwater

33770

Research Facility, Largo

33907

Research Facility, Fort Myers

36207

Research Facility, Anniston

36608

Coastal Clinical Research, Inc., Mobile

39531

Research Facility, Biloxi

43213

Research Facility, Columbus

43235

Research Facility, Columbus

43623

Research Facility, Toledo

45242

Research Facility, Cincinnati

45245

Community Research, Cincinnati

46250

Rehabilitation Association of IN, Indianapolis

48706

Research Facility, Bay City

63031

Research Facility, Florissant

63117

Research Facility, St Louis

63141

Research Facility, St Louis

Sports Med Consultants, PC, St Louis

66206

CTT Consultants, Inc., Prairie Village

66211

Research Facility, Overland Park

70114

Research Facility, New Orleans

70115

Research Facility, New Orleans

70809

Dolby Research, LLC, Baton Rouge

71103

Research Facility, Shreveport

73109

Research Facility, Oklahoma City

75093

Research Facility, Plano

75230

KRK Medical Research, Dallas

76543

Research Facility, Killeen

77479

Research Facility, Sugarland

78229

Research Facility, San Antonio

80128

Research Facility, Littleton

83702

Research Facility, Boise

84106

Research Facility, Salt Lake City

85023

Arizona Research Center Inc., Phoenix

85029

Research Facility, Phoenix

85032

Research Facility, Phoenix

85225

Radiant Research; Phoenix Southeast, Chandler

87108

Lovelace Scientific Resources, Albuquerque

89014

Research Facility, Henderson

89123

Research Facility, Las Vegas

90211

Lovelace Scientific Resources, Inc., Beverly Hills

90241

Research Facility, Downey

91748

Advance Care Medical Group, City of Industry

92610

Research Facility, Foothill Ranch

92801

Research Facility, Anaheim

93405

Research Facility, San Luis Obispo

95608

Research Facility, Carmichael

95831

Research Facility, Sacramento

97404

Research Facility, Eugene

06905

Research Facility, Stamford

32117-2257

Century Clinical Research, Inc., Holly Hill

33458-7200

Research Facility, Jupiter

96814-4526

Research Facility, Honolulu

02301

Research Facility, Brockton

01830-6141

East Coast Clinical Research, Haverhill

01103

Research Facility, Springfield

97504-8311

Research Facility, Medford

02920

New England Center for Clinical Research, Cranston

78205-1116

Research Facility, San Antonio

All Listed Sponsors
lead

Purdue Pharma LP

INDUSTRY

NCT00490919 - Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain | Biotech Hunter | Biotech Hunter